lamotrigine has been researched along with Common Variable Hypogammaglobulinemia in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lamotrigine (LTG) is an anti-epileptic drug and mood-stabilizing agent, whose adverse effects include skin rash and dizziness." | 1.43 | Immunoglobulin A deficiency following treatment with lamotrigine. ( Hanaya, R; Kawano, Y; Maruyama, S; Okamoto, Y; Toyoshima, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruyama, S | 1 |
| Okamoto, Y | 1 |
| Toyoshima, M | 1 |
| Hanaya, R | 1 |
| Kawano, Y | 1 |
| Smith, J | 1 |
| Fernando, T | 1 |
| McGrath, N | 1 |
| Ameratunga, R | 1 |
2 other studies available for lamotrigine and Common Variable Hypogammaglobulinemia
| Article | Year |
|---|---|
Immunoglobulin A deficiency following treatment with lamotrigine.
Topics: Adolescent; Anticonvulsants; Common Variable Immunodeficiency; Epilepsy; Female; Humans; IgA Deficie | 2016 |
Lamotrigine-induced common variable immune deficiency.
Topics: Common Variable Immunodeficiency; Epilepsy, Generalized; Excitatory Amino Acid Antagonists; Humans; | 2004 |